Yamada, Chieko
Kubota, Takuo https://orcid.org/0000-0003-4483-4405
Nakayama, Hirofumi
Ohata, Yasuhisa
Okamura, Satomi
Yamamoto, Kenichi
Fujiwara, Makoto
Ozono, Keiichi
Kitabatake, Yasuji
Funding for this research was provided by:
The University of Osaka
Article History
Received: 9 November 2025
Accepted: 22 March 2026
First Online: 27 April 2026
Declarations
:
: Takuo Kubota has received research grants, honorarium, and consultant fees from Teijin Pharma. The other authors have no conflicts of interest to declare.
: This study was approved by the Research Ethics Committee of the University of Osaka (approval number: 688-11, 23386-2). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all patients included in the study.